We conclude that in a patient with IL-12Rβ1 deficiency, IFN-γ at a dose of 200 μg/m2, but not at lower dosages, was found to have a noticeable clinical effect with no additional adverse effects. Here, IL12RB1 is linked to hyperinsulinemic hypoglycemia, familial, 4.